Alemtuzumab
Trade Names:
Campath®
Possible Uses:
Approved for B-Cell chronic lymphocytic leukemia. Also used for T-cell lymphoma and leukemia.
Special Notes:
Can be given by IV infusion and SQ injection
Drug Interactions:
echinacea
Possible Side Effects:
Low blood pressure, edema, fever, chills, fatigue, headache,rash, neasuea, vomiting, diarrhea, mucositis.
Lymphopenia is significant as well as neutropenia, anemia, and low platelets.
Rigors, cough, and infections can occur. Last updated on 02/01/2010
